Delivery Order SPE2DB24D6039-SPE2DB25FLEFX
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999.71 contract is for the delivery of 4,567,828,683 units of the prescription medication Contrave ER 8-90 mg tablets. The contract has an ultimate completion date of April 8, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,781.54, is for the delivery of the prescription medication Contrave ER 8-90 mg Tablet 120s. The contract has a period of performance through March 18, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,243,433 tablets of the drug Contrave ER 8-90 mg, with a ceiling value of $1,199.01. The contract is a firm fixed price Delivery Order with a completion date of July 25, 2024. This contract is not designated as a set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,179.39, is for the delivery of the prescription medication Contrave ER 8-90 mg tablet in quantities of 120 per order. The contract is a firm fixed-price, non-set-aside agreement with a completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Contrave ER 8-90 mg tablets. The contract has a ceiling value of $20,461.90 and a period of performance through April 14, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,204.31, is for the supply of Contrave ER 8-90 mg tablets. It is a firm fixed-price, delivery order contract with a completion date of May 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,875.62, is for the delivery of the drug Contrave ER 8-90 mg Tablet in quantities of 120 tablets. The contract has an ultimate completion date of January 17, 2024, and was awarded on January 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,423.20, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has a completion date of July 16, 2024 and is a firm fixed-price contract. AmerisourceBergen, a for-profit organization, is the prime contractor and there is no set-aside designation for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,250.40 award is for the supply of 4,563,898,453 units of the medication Contrave ER 8-90 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,060.40, is for the delivery of the prescription medication Contrave ER 8-90 mg tablet in quantities of 120 per bottle. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a substantial...